StonvexLoading…
StonvexStonvexStonvexCore line items from CVS's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2018 2018-12-31 | Annual 2017 2017-12-31 | Annual 2016 2016-12-31 |
|---|---|---|---|
Revenue | $193.92B | $184.76B | $177.53B |
Operating Income | $4.02B | $9.54B | $10.39B |
Net Income | $-594.00M | $6.62B | $5.32B |
EPS (Diluted) | $-0.57 | $6.44 | $4.90 |
Total Assets | $196.46B | $95.13B | $94.46B |
Total Liabilities | $137.91B | $57.44B | Not available |
Cash & Equivalents | $4.06B | $1.70B | $3.37B |
Free Cash Flow OCF − CapEx | $6.83B | $6.09B | $7.92B |
Shares Outstanding | 1.29B | 1.01B | 1.06B |